| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V121115 | ((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane | 2621932-37-2 | ((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V121119 | ((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate | 2346620-55-9 | ((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V121310 | (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid | 791594-13-3 | (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V121311 | (1R,2R)-2-(Pyridin-3-yl)cyclopropane-1-carboxylic acid | 1423769-08-7 | (1R,2R)-2-(Pyridin-3-yl)cyclopropane-1-carboxylic acid is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V121322 | (1S,2R)-2-Fluorocyclopropan-1-amine hydrochloride | 141042-20-8 | (1S,2R)-2-Fluorocyclopropan-1-amine hydrochloride is a pharmaceutical impurity. |
|
V111966 | (1S,3R)-3-Benzoic acid 3-carboxycyclopentyl ester | (1S,3R)-3-benzoic acid 3-carboxycyclopentyl ester ((1S,3R)-3-(benzoyloxy)cyclopentanecarboxylic acid) is a pharmaceutical intermediate. | |
|
V107699 | (1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester | 1292307-06-2 | Methyl (1S,3R)-3-Hydroxycyclopentanecarboxylate is a synthetic intermediate used in drug synthesis. |
|
V111156 | (1S,3S)-3-Hydroxycyclopentane carboxylic acid benzyl ester | 1536118-70-3 | (1S,3S)-3-hydroxycyclopentanecarboxylic acid benzyl ester ((1S,3S)-benzyl-3-hydroxycyclopentanecarboxylic acid ester) is a synthetic intermediate. |
|
V121444 | (2R,5S)-1-tert-Butyl 2-ethyl 5-aminopiperidine-1,2-dicarboxylate | 2411590-87-7 | (2R,5S)-1-tert-Butyl 2-ethyl 5-aminopiperidine-1,2-dicarboxylate is a pharmaceutical intermediate used in the synthesis of various active compounds. |
|
V121471 | (2S,4S)-1-((S)-2-Amino-3,3-Dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride | 2380273-26-5 | (2S,4S)-1-((S)-2-Amino-3,3-Dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V121472 | (2S,4S)-1-(tert-Butoxycarbonyl)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxylic acid | 1821705-03-6 | (2S,4S)-1-(tert-Butoxycarbonyl)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxylic acid is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V121640 | (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Dichloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate Beclometasone Dipropionate Impurity | 887130-68-9 | (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Dichloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(pro pionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate Beclometasone Dipropionate Impurity is an impurity. |
|
V121641 | (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate Beclometasone Dipropionate Impurity | 887130-69-0 | (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(p ropionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate Beclometasone Dipropionate Impurity is an impurity. |
|
V121744 | (E)-4-(Naphthalen-2-yl)but-3-en-2-one | 51557-10-9 | (E)-4-(Naphthalen-2-yl)but-3-en-2-one is a small, active molecule that can be used as a structural unit. |
|
V121764 | (E)-Betamethasone impurity 4 | (E)-Betamethasone impurity 4 is an impurity of E-betamethasone. | |
|
V121844 | (R)-(+)-Trityl glycidyl ether | 65291-30-7 | (R)-(+)-Trityl glycidyl ether is a heterocyclic compound that is a precursor for the synthesis of glycerophospholipids and compounds with antiviral and antimalarial activities. |
|
V121848 | (R)-1-(tert-Butoxycarbonyl)-2-methylpiperidine-2-carboxylic acid | 1415566-32-3 | (R)-1-(tert-Butoxycarbonyl)-2-methylpiperidine-2-carboxylic acid is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V121968 | (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate | 877399-51-4 | (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate is a pharmaceutical intermediate for the synthesis of various active compounds. |
|
V106546 | (R)-Tetrahydrofuran-2-yl-methylamine | 7202-43-9 | (R)-Tetrahydrofuran-2-yl-methylamine (1-[(2R)-tetrahydrofuran-2-yl]methylamine) is a synthetic intermediate that can be used in drug synthesis. |
|
V122056 | (Rp,R'p)-(R)-Mandyphos | 210842-74-3 | (Rp,R'p)-(R)-Mandyphos is a pharmaceutical intermediate for the synthesis of various active compounds. |